bpc-157 derived from gastric protein BPC 157 | | 137525-51-0 The "Body Protection Compound": A

Professor and Chair, Department of Nutritional Sciences Rutgers, The State University of New Jersey Copyright 2000-2026 Linus Pauling Institute Figure Alternative Text Figure 1

Any reference to dosage should be understood only in a laboratory research context and should not be taken as medical advice

Studies have indicated that AOD-9604 can stimulate lipolysis without affecting insulin or IGF1 levels, suggesting that it may not lead to the development of diabetes or glucose intolerance

BPC-157 reduced enteric serotonin release, suppressing intestinal motility

Rescue therapy was needed by 8%, 25%, and 67%, respectively. Five milligrams preserved most, but not all, of the benefit of continuing the effective dose

Archived from the original on 13 September 2017